Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INI101 vs Botox for moderate-to-severe glabellar lines
CTR20233530Phase 3Completed
- Sponsor
- Inibio
- Start
- Nov 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of INI101 in glabellar furrowing, sponsored by Inibio. Started Nov 2023; status: completed.
02
Drugs
INI101
03
Conditions
glabellar furrowing
Beyond the preview
Go deeper on CTR20233530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233530.